IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO‐RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END‐POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK. (June 2017) - Soussain, C.; Choquet, S.; Houillier, C.; Bijou, F.; Houot, R.; Boyle, E.; Gressin, R.; Nicolas‐Virelizier, E.; Barrie, M.; Moluçon‐Chabrot, C.; Lelez, M.; Clavert, A.; et al.